Advanced search
Publication Cover
Current Medical Research and Opinion Volume 31, 2015 - Issue 10
Submit an article Journal homepage
949
Views
11
CrossRef citations to date
0
Altmetric
Original article

Effect of ivabradine on numbers needed to treat for the prevention of recurrent hospitalizations in heart failure patients

Jennifer K. RogersDepartment of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom;MRC Clinical Trials Unit at UCL, London, United KingdomCorrespondence[email protected]
,
Adrian KielhornGlobal Health Economics, Amgen, Inc., Thousand Oaks, CA, USA
,
Jeffrey S. BorerThe Howard Gilman and Ronald and Jean Schiavone Institutes, State University of New York Downstate Medical Center, New York, USA
,
Ian FordRobertson Centre for Biostatistics, University of Glasgow, Glasgow, United Kingdom
&
Stuart J. PocockDepartment of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom
Pages 1903-1909 | Accepted 03 Aug 2015, Published online: 18 Aug 2015

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Zeba M. Khan, Jean Baptiste Briere, Elzbieta Olewinska, Fatma Khrouf & Mateusz Nikodem. (2023) Ivabradine in patients with heart failure: a systematic literature review. Journal of Market Access & Health Policy 11:1.
Read now
Anupama Vasudevan, James W. Choi, Georges A. Feghali, Aaron Y. Kluger, Stuart R. Lander, Kristen M. Tecson, Mohanakrishnan Sathyamoorthy, Jeffrey M. Schussler, Robert C. Stoler, Ravi C. Vallabhan, Carlos E. Velasco, Anthony Yoon & Peter A. McCullough. (2019) First and recurrent events after percutaneous coronary intervention: implications for survival analyses. Scandinavian Cardiovascular Journal 53:6, pages 299-304.
Read now

Articles from other publishers (9)

Muthiah Vaduganathan, Brian L. Claggett, Stephen J. Greene, Rahul Aggarwal, Ankeet S. Bhatt, John J. V. McMurray, Gregg C. Fonarow & Scott D. Solomon. (2021) Potential Implications of Expanded US Food and Drug Administration Labeling for Sacubitril/Valsartan in the US. JAMA Cardiology 6:12, pages 1415.
Crossref
Umair Ali, Tanveer Ahmad, Jehanzeb Khan, Muhammad ijaz Khan, Hurriya Khan & Bilal Javed. (2021) Comparison of Efficacy of Ivabradine With Traditional Therapy in Patients With Left Ventricular Dysfunction. Cureus.
Crossref
Pardeep S. Jhund, Piotr PonikowskiKieran F. DochertySamvel B. Gasparyan, Michael Böhm, Chern-En ChiangAkshay S. Desai, Jonathon HowlettMasafumi KitakazeMark C. Petrie, Subodh Verma, Olof BengtssonAnna-Maria LangkildeMikaela SjöstrandSilvio E. InzucchiLars KøberMikhail N. Kosiborod, Felipe A. MartinezMarc S. Sabatine, Scott D. Solomon & John J.V. McMurray. (2021) Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF. Circulation 143:20, pages 1962-1972.
Crossref
Tomomi Ide, Kisho Ohtani, Taiki Higo, Makoto TanakaYasushi KawasakiHiroyuki Tsutsui. (2019) Ivabradine for the Treatment of Cardiovascular Diseases. Circulation Journal 83:2, pages 252-260.
Crossref
Bruno M.L. Rocha & Luiz Menezes Falcão. (2016) Acute decompensated heart failure (ADHF): A comprehensive contemporary review on preventing early readmissions and postdischarge death. International Journal of Cardiology 223, pages 1035-1044.
Crossref
Muthiah Vaduganathan, Ravi B. Patel, Stephen J. Greene & Mihai Gheorghiade. (2016) Targeting the vulnerable phase of heart failure: initiate novel therapies in stable patients prior to hospitalization. European Journal of Heart Failure 18:9, pages 1190-1192.
Crossref
Jeffrey S. Borer & Luigi Tavazzi. (2016) Update on ivabradine for heart failure. Trends in Cardiovascular Medicine 26:5, pages 444-449.
Crossref
Antonio Carlos Pereira-Barretto. (2016) Addressing Major Unmet Needs in Patients with Systolic Heart Failure: The Role of Ivabradine. American Journal of Cardiovascular Drugs 16:2, pages 93-101.
Crossref
Michael S. Kapiloff & Craig A. Emter. (2016) The cardiac enigma: current conundrums in heart failure research. F1000Research 5, pages 72.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.